Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Swedish Orphan Biovitrum AB (publ)?

Accepted Answer

Según el último estado financiero (Form-10K), Swedish Orphan Biovitrum AB (publ) tiene un total de activos de $75,444, una ganancia neta profit de $3,885

Question 2

¿Cuáles son los ratios financieros clave para BIOVF?

Accepted Answer

El ratio corriente de Swedish Orphan Biovitrum AB (publ) es 2.14, el margen neto es 14.92, las ventas por acción son $75.31.

Question 3

¿Cómo se desglosan los ingresos de Swedish Orphan Biovitrum AB (publ) por segmento o geografía?

Accepted Answer

Swedish Orphan Biovitrum AB (publ) largest revenue segment is Haematology, at a revenue of 13,370,000,000 in the most earnings release.For geography, United States is the primary market for Swedish Orphan Biovitrum AB (publ), at a revenue of 8,148,000,000.

Question 4

¿Es rentable Swedish Orphan Biovitrum AB (publ)?

Accepted Answer

yes, según los últimos estados financieros, Swedish Orphan Biovitrum AB (publ) tiene una ganancia neta profit de $3,885

Question 5

¿Tiene Swedish Orphan Biovitrum AB (publ) alguna deuda?

Accepted Answer

yes, Swedish Orphan Biovitrum AB (publ) tiene una deuda de 35,158

Question 6

¿Cuántas acciones en circulación tiene Swedish Orphan Biovitrum AB (publ)?

Accepted Answer

Swedish Orphan Biovitrum AB (publ) tiene un total de acciones en circulación de 343.44

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	27,851	26,027	22,123	18,790	15,529	15,261
Revenue Growth (YoY)	10%	18%	18%	21%	2%	7%
Cost of Revenue	6,075	5,717	4,952	4,413	3,484	3,225
Gross Profit	21,776	20,310	17,171	14,377	12,045	12,036
Selling, General & Admin	-1,541	7,302	6,668	5,415	4,341	4,007
Research & Development	3,352	3,503	2,719	2,228	1,981	1,581
Operating Expenses	14,633	14,488	12,495	9,856	8,258	7,573
Other Non Operating Income (Expenses)	0	-59	-51	-28	-35	-33
Pretax Income	-699	4,407	2,954	3,321	3,295	4,217
Income Tax Expense	-704	528	546	683	616	972
Net Income	14	3,885	2,409	2,638	2,679	3,245
Net Income Growth	-100%	61%	-9%	-2%	-17%	-2%
Shares Outstanding (Diluted)	344.64	345.56	325.96	312.45	310.72	311.6
Shares Change (YoY)	-1%	6%	4%	1%	0%	6%
EPS (Diluted)	0.04	11.24	7.39	8.44	8.62	10.41
EPS Growth	-100%	52%	-12%	-2%	-17%	-7%
Free Cash Flow	4,209	4,383	-473	3,099	5,100	1,074
Free Cash Flow Per Share	12.21	12.68	-1.45	9.91	16.41	3.44
Gross Margin	78.18%	78.03%	77.61%	76.51%	77.56%	78.86%
Operating Margin	25.64%	22.36%	21.13%	24.06%	24.38%	29.24%
Profit Margin	0.05%	14.92%	10.88%	14.03%	17.25%	21.26%
Free Cash Flow Margin	15.11%	16.84%	-2.13%	16.49%	32.84%	7.03%
EBITDA	17,417	9,501	7,876	6,940	5,793	6,486
EBITDA Margin	62.53%	36.5%	35.6%	36.93%	37.3%	42.5%
D&A For EBITDA	10,274	3,679	3,200	2,419	2,006	2,023
EBIT	7,143	5,822	4,676	4,521	3,787	4,463
EBIT Margin	25.64%	22.36%	21.13%	24.06%	24.38%	29.24%
Effective Tax Rate	100.71%	11.98%	18.48%	20.56%	18.69%	23.04%

Swedish Orphan Biovitrum AB (publ) (BIOVF) Price

BIOVF Stock Price Chart

BIOVF Income

Follow-Up Questions